Cyclerion Therapeutics, Inc. (CYCN)
NASDAQ: CYCN · Real-Time Price · USD
3.335
+0.115 (3.57%)
Jun 23, 2026, 2:02 PM EDT - Market open
Cyclerion Therapeutics Market Cap
Cyclerion Therapeutics has a market cap or net worth of $14.14 million as of June 23, 2026. Its market cap has increased by 38.56% in one year.
Market Cap
14.14M
Enterprise Value
10.83M
1-Year Change
38.56%
Ranking
Category
Stock Price
$3.34
Market Cap Chart
Since March 18, 2019, Cyclerion Therapeutics's market cap has decreased from $193.31M to $14.14M, a decrease of -92.68%. That is a compound annual growth rate of -30.21%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 23, 2026 | 14.14M | 192.61% |
| Dec 31, 2025 | 4.83M | -40.68% |
| Dec 31, 2024 | 8.15M | -0.51% |
| Dec 29, 2023 | 8.19M | -71.30% |
| Dec 30, 2022 | 28.54M | -61.69% |
| Dec 31, 2021 | 74.50M | -28.31% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Mar 18, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| BioVie | 14.63M |
| Lexaria Bioscience | 14.45M |
| IN8bio | 14.38M |
| BioLineRx | 14.10M |
| Jasper Therapeutics | 14.04M |
| Cocrystal Pharma | 13.79M |
| Traws Pharma | 13.51M |
| SeaStar Medical Holding | 13.03M |